Recent Articles

Fat Cells May Hinder Effectiveness of Chemotherapy

| December 4, 2017 | 0 Comments

Fat Cells May Hinder Effectiveness of Chemotherapy For the first time, researchers have shown that fat cells can absorb two commonly used chemotherapy drugs and break them down chemically into a less toxic form, potentially reducing the drugs’ effectiveness. See Original Article

Continue Reading

Expanding Cancer Clinical Trial Access for Patients with HIV

| December 1, 2017 | 0 Comments

Expanding Cancer Clinical Trial Access for Patients with HIV People with HIV are often excluded from clinical trials for safety reasons. Preliminary results from an NCI-sponsored study of an immunotherapy drug show that people with HIV can safely participate in clinical trials.See Original Article

Continue Reading

Dasatinib Approved by FDA for Some Children with Chronic Myelogenous Leukemia

| November 30, 2017 | 0 Comments

Dasatinib Approved by FDA for Some Children with Chronic Myelogenous Leukemia On November 9, the FDA approved dasatinib (Sprycel®) for the treatment of children with chronic myelogenous leukemia (CML) whose cancer cells express the Philadelphia chromosome and whose disease is in a relatively early stage, known as the chronic phase. See Original Article

Continue Reading

TMIST Trial Aims to Provide Clarity on Breast Cancer Screening Approaches

| November 29, 2017 | 0 Comments

TMIST Trial Aims to Provide Clarity on Breast Cancer Screening Approaches A large nationwide clinical trial called TMIST has been launched to compare two techniques used for mammograms: tomosynthesis, often called 3D mammography, and standard 2D digital mammography.See Original Article

Continue Reading

An Important Moment in Tobacco Control

| November 28, 2017 | 0 Comments

An Important Moment in Tobacco Control November 26, 2017, marked a unique moment in US public health history, with the major US tobacco companies issuing the first in a series of court-ordered “corrective statements” about their products. See Original Article

Continue Reading

Expanding Smoking Cessation Services at NCI-designated Cancer Centers: An Interview with Dr. Glen Morgan

| November 22, 2017 | 0 Comments

Expanding Smoking Cessation Services at NCI-designated Cancer Centers: An Interview with Dr. Glen Morgan NCI’s Dr. Glen Morgan discusses NCI’s Cancer Center Cessation Initiative, including how and why this smoking cessation initiative was developed and its long-term goals.See Original Article

Continue Reading

Endometrial Cancer Incidence Rising in the US and Worldwide

| November 20, 2017 | 0 Comments

Endometrial Cancer Incidence Rising in the US and Worldwide Diagnoses of endometrial cancer have increased worldwide in recent years, with rates rising in more than half of the 43 countries studied during the decade ending around 2010, a team of international researchers has shown. See Original Article

Continue Reading

Experimental Ovarian Cancer Vaccine Shows Promise in Mice

| November 17, 2017 | 0 Comments

Experimental Ovarian Cancer Vaccine Shows Promise in Mice The vaccine targets a protein found at elevated levels in about 90% of the most common type of ovarian cancer. If validated in human studies, researchers believe the vaccine may be particularly useful for women who carry BRCA1 and BRCA2 gene mutations.See Original Article

Continue Reading

Many Ovarian Cancers May Start in Fallopian Tubes, Study Finds

| November 15, 2017 | 0 Comments

Many Ovarian Cancers May Start in Fallopian Tubes, Study Finds A new study provides more evidence that the most common form of ovarian cancer may originate in the fallopian tubes, and that there is a window of nearly 7 years between development of fallopian tube lesions and the start of ovarian cancer.See Original Article

Continue Reading

Alternate Driver of Treatment-Resistant Prostate Cancer Identified

| November 14, 2017 | 0 Comments

Alternate Driver of Treatment-Resistant Prostate Cancer Identified Researchers have identified an emerging subtype of metastatic prostate cancer that is resistant to therapies that block hormones that fuel the disease.See Original Article

Continue Reading